Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Novo Nordisk Invests More Than 16 Billion Danish Kroner in Expansion of Production Facilities in Chartres, France
Friday, November 24, 2023Novo Nordisk today announced the investment of more than billion Danish kroner starting in to expand the existing production site in Chartres France for the current and future product
Sandoz Launches Hyrimoz® (Adalimumab) High-concentration Formulation in Europe, Aiming to Improve Patient Care
Wednesday, November 22, 2023Sandoz the global leader in generic and biosimilar medicines today announces the launch of Hyrimoz citratefree high concentration formulation HCF mgmL in Europe The medicine
Biocryst Launches ORLADEYO® (Berotralstat) in Spain
Wednesday, November 22, 2023BioCryst Pharmaceuticals Inc today announced that the Spanish Ministry for Health has granted marketing authorization for oral oncedaily ORLADEYO for the routine prevention of recurrent
Ascendis Pharma Announces European Commission Approval of YORVIPATH® (palopegteriparatide) for the Treatment of Adults with Chronic Hypoparathyroidism
Tuesday, November 21, 2023Ascendis Pharma AS today announced that the European Commission has granted marketing authorization for YORVIPATH as replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism
Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder
Tuesday, November 21, 2023Yamo Pharmaceuticals LLC a clinical stage pharmaceutical company announced today that it has completed enrollment in its Phase study evaluating L in adolescents and young adults with autism spectrum disorder
Fortrea Announces AI-driven Partnership With Medidata to Increase Diversity in Clinical Trials
Monday, November 20, 2023Fortrea a leading global contract research organization today announced a partnership with Medidata a Dassault Systmes company and leading provider of clinical trial solutions to the life sciences industry
IN8bio’s INB-200 Demonstrates Extended Progression-free Survival in Patients With Newly Diagnosed Glioblastoma
Monday, November 20, 2023INbio Inc a leading clinicalstage biopharmaceutical company developing innovative gammadelta T cell therapies presented data demonstrating that all patients treated with INB
Lilly to Expand Injectable Manufacturing Capacity With Planned $2.5 Billion Site in Germany
Saturday, November 18, 2023Eli Lilly and Company today announced plans to construct a new billion hightech manufacturing site in Alzey RhinelandPalatinate Germany This new facility will further expand the companys global parenteral
Uppsala University Hospital and Sana Biotechnology Authorized for First-in-Human Trial of Primary Islet Cell Treatment for Type 1 Diabetes
Saturday, November 18, 2023Sana Biotechnology Inc a company focused on changing the possible for patients through engineered cells and Uppsala University Hospital in Sweden today announced the Swedish Medical Products
Complete Genomics Opens $3.2 Million Manufacturing Facility at Its San Jose Headquarters
Friday, November 17, 2023Complete Genomics a pioneering genomic sequencing company today announced plans for the opening of a million manufacturing facility within its headquarters in San Jose California The facility scheduled to open in March
